|
|
||||||||

*
Schepens Eye Research Institute and Pulmonary and Critical Care Division, Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, MA 02114; and
Massachusetts Institute of Technology, Undergraduate Research Opportunities Program, Cambridge, MA 02139
Pulmonary interstitial fibrosis (PIF), associated with persistent
inflammation and increased collagen deposition in the interstitium, is
often considered an autoimmune disease. Hapten immune PIF (HIPIF), a
model for PIF, is elicited in the lung by a single intratracheal (i.t.)
challenge in mice sensitized with hapten (2,4,6-trinitrobenzene
sulfonic acid, TNBS). In this study, we characterized the role of
CD40/CD40 ligand (CD40L) interactions in the elicitation of secondary
cell-mediated immune responses that lead to development of fibrosis in
the lung using an adoptive transfer model of HIPIF. The expression of
CD40 was detected on bronchoalveolar lavage (BAL) cells 13 days after
i.t. challenge with hapten in the HIPIF lung, but not lungs from the
control mice. The CD40bright BAL cells morphologically
resembled infiltrating monocytes. Furthermore, blocking CD40/CD40L
interactions with blocking Ab decreased BAL production of Th1-mediators
(IL-12 and TNF-
). Moreover, either blocking CD40/CD40L interactions
with the Ab or using IL-12 knockout recipient mice prevented the
increased collagen deposition (accumulation of hydroxyproline) in the
lungs during HIPIF induction. We conclude that second signals
(CD40/CD40L interactions) are required for elicitation of secondary
immune responses that lead to PIF in vivo. The results support the
notion that CD40/CD40L interactions are involved in the pathogenesis of
an ongoing autoimmune disease.
This article has been cited by other articles:
![]() |
A. Liu, A. Guardino, L. Chinsangaram, M. J. Goldstein, D. Panicali, and R. Levy Therapeutic Vaccination against Murine Lymphoma by Intratumoral Injection of Recombinant Fowlpox Virus Encoding CD40 Ligand Cancer Res., July 15, 2007; 67(14): 7037 - 7044. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Wagner-Ballon, H. Chagraoui, E. Prina, M. Tulliez, G. Milon, H. Raslova, J.-L. Villeval, W. Vainchenker, and S. Giraudier Monocyte/Macrophage Dysfunctions Do Not Impair the Promotion of Myelofibrosis by High Levels of Thrombopoietin. J. Immunol., June 1, 2006; 176(11): 6425 - 6433. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Marchal-Somme, Y. Uzunhan, S. Marchand-Adam, D. Valeyre, V. Soumelis, B. Crestani, and P. Soler Cutting Edge: Nonproliferating Mature Immune Cells Form a Novel Type of Organized Lymphoid Structure in Idiopathic Pulmonary Fibrosis J. Immunol., May 15, 2006; 176(10): 5735 - 5739. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Pryhuber, H. L. Huyck, J. M. Roper, J. Cornejo, M. A. O'Reilly, R. H. Pierce, and E. N. Tsitsikov Acute Tumor Necrosis Factor-{alpha}-Induced Liver Injury in the Absence of Tumor Necrosis Factor Receptor-Associated Factor 1 Gene Expression Am. J. Pathol., June 1, 2005; 166(6): 1637 - 1645. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hashimoto, T. Kawabe, K. Imaizumi, T. Hara, M. Okamoto, K. Kojima, K. Shimokata, and Y. Hasegawa CD40 Plays a Crucial Role in Lipopolysaccharide-Induced Acute Lung Injury Am. J. Respir. Cell Mol. Biol., June 1, 2004; 30(6): 808 - 815. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang-Hoover and J. Stein-Streilein Tolerogenic APC Generate CD8+ T Regulatory Cells That Modulate Pulmonary Interstitial Fibrosis J. Immunol., January 1, 2004; 172(1): 178 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tsutsumi, K.-H. Sonoda, K. Egashira, H. Qiao, T. Hisatomi, S. Nakao, M. Ishibashi, I. F. Charo, T. Sakamoto, T. Murata, et al. The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization J. Leukoc. Biol., July 1, 2003; 74(1): 25 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhao, Y. Qian, D. Wald, Y.-F. Xia, J.-G. Geng, and X. Li IFN Regulatory Factor-1 Is Required for the Up-Regulation of the CD40-NF-{kappa}B Activator 1 Axis During Airway Inflammation J. Immunol., June 1, 2003; 170(11): 5674 - 5680. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Atamas, I. G. Luzina, H. Dai, S. G. Wilt, and B. White Synergy Between CD40 Ligation and IL-4 on Fibroblast Proliferation Involves IL-4 Receptor Signaling J. Immunol., February 1, 2002; 168(3): 1139 - 1145. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |